Novak Djokovic 2026 Tennis Topps NOW card 1EXACT CARD · SOURCE LINKED

ICX RECORD · 2026

Novak Djokovic

2026 Tennis Topps NOW · #1 · Base · Raw

Centurion: wins his 100th Australian Open match

A round-number tournament milestone for one of tennis’s defining players. The confirmed print run is useful context, but exact completed-sale depth is still needed before any valuation call.

WATCH78/100 ICX SIGNAL
01 / SUBJECTNovak DjokovicTennis
02 / COLLECTION2026 Tennis Topps NOWTopps NOW Tennis
03 / CARD#1 · BaseTopps
04 / FORMATRawIdentity resolved

SUPPLY TRUTH

What is known.
What is still missing.

FINAL PRINT RUN
2,890
ORIGINAL PRICE
$11.99
ORDER WINDOW
20 Jan 2026 · sold out
CHASE / VARIANTS
Foil parallels /50 to /1; autograph redemption /1

FIVE-LANE MARKET CHECK

Market evidence,
without scarcity theatre.

Active listings are availability signals only. Value requires inspectable completed transactions for the exact identity and format.

PARTIALEurope active supply

Exact-card European search route supplied; listing depth has not been normalized for this record.

Supply only; active asks are not comps.

Open evidence ↗
PARTIALUSA active supply

Exact-card search route supplied; current listings may change after publication.

Supply only; active asks are not comps.

Open evidence ↗
MISSINGEurope completed sales

No inspectable exact-card transaction series was captured for this record.

No valuation conclusion.

No source captured
MISSINGUSA completed sales

No inspectable exact-card transaction series was captured for this record.

No valuation conclusion.

No source captured
MISSINGOther completed results

No additional exact-card auction or marketplace result was captured.

No valuation conclusion.

No source captured

THE ICX READING

Centurion: wins his 100th Australian Open match

A round-number tournament milestone for one of tennis’s defining players. The confirmed print run is useful context, but exact completed-sale depth is still needed before any valuation call.

Watch: the card belongs in the archive, but evidence is not yet strong enough for a purchase or valuation conclusion.